| Primary |
| Burkitt's Lymphoma |
12.9% |
| Lymphoma |
12.1% |
| Neoplasm Malignant |
12.1% |
| Non-hodgkin's Lymphoma |
8.6% |
| Hodgkin's Disease |
7.8% |
| Acute Lymphocytic Leukaemia |
6.9% |
| B-cell Lymphoma |
6.9% |
| Liposarcoma |
4.3% |
| Multiple Myeloma |
4.3% |
| Plasma Cell Myeloma |
4.3% |
| Breast Cancer |
3.4% |
| Premedication |
3.4% |
| Neuroblastoma |
2.6% |
| Pneumonia |
2.6% |
| Chemoembolization |
1.7% |
| Infection Prophylaxis |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Antibiotic Therapy |
0.9% |
| Epilepsy |
0.9% |
| Hepatocellular Carcinoma |
0.9% |
|
| Febrile Bone Marrow Aplasia |
12.5% |
| Leukopenia |
9.4% |
| Pulmonary Fibrosis |
9.4% |
| Gamma-glutamyltransferase Increased |
6.3% |
| Respiratory Distress |
6.3% |
| Second Primary Malignancy |
6.3% |
| Tremor |
6.3% |
| Type 1 Diabetes Mellitus |
6.3% |
| Aplasia |
3.1% |
| Cerebral Haemorrhage |
3.1% |
| Congestive Cardiomyopathy |
3.1% |
| Cytolytic Hepatitis |
3.1% |
| Dyspnoea |
3.1% |
| Gastrointestinal Necrosis |
3.1% |
| Heart Disease Congenital |
3.1% |
| Left Ventricular Failure |
3.1% |
| Melanocytic Naevus |
3.1% |
| Methaemoglobinaemia |
3.1% |
| Myocardial Ischaemia |
3.1% |
| Nervous System Disorder |
3.1% |
|
| Secondary |
| Non-hodgkin's Lymphoma |
14.7% |
| Drug Use For Unknown Indication |
14.3% |
| Hodgkin's Disease |
13.9% |
| Product Used For Unknown Indication |
13.9% |
| Lymphoma |
6.3% |
| Mantle Cell Lymphoma |
5.9% |
| Burkitt's Lymphoma |
5.1% |
| B-cell Lymphoma |
4.8% |
| Liposarcoma |
3.0% |
| T-cell Lymphoma |
3.0% |
| Premedication |
2.8% |
| Anaplastic Large Cell Lymphoma T- And Null-cell Types |
2.4% |
| Bronchial Carcinoma |
1.6% |
| Diffuse Large B-cell Lymphoma |
1.6% |
| Hypertension |
1.2% |
| Leiomyosarcoma Recurrent |
1.2% |
| Small Cell Lung Cancer Metastatic |
1.2% |
| Chronic Lymphoid Leukemia |
1.0% |
| Small Cell Lung Cancer |
1.0% |
| Lung Neoplasm Malignant |
0.8% |
|
| Syncope |
12.9% |
| Cytolytic Hepatitis |
8.1% |
| Acute Myeloid Leukaemia |
6.5% |
| Sigmoiditis |
6.5% |
| Tremor |
6.5% |
| Troponin Increased |
6.5% |
| Cardiomyopathy |
4.8% |
| Febrile Bone Marrow Aplasia |
4.8% |
| Respiratory Distress |
4.8% |
| Septic Shock |
4.8% |
| Thrombocytopenia |
4.8% |
| Atrial Fibrillation |
3.2% |
| Cerebral Haemorrhage |
3.2% |
| Mycotic Aneurysm |
3.2% |
| Nervous System Disorder |
3.2% |
| Neurotoxicity |
3.2% |
| Pulmonary Toxicity |
3.2% |
| Sarcoma |
3.2% |
| Squamous Cell Carcinoma Of The Cervix |
3.2% |
| Staphylococcal Infection |
3.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.6% |
| Product Used For Unknown Indication |
19.0% |
| Lymphoma |
7.0% |
| Chemotherapy |
5.6% |
| Hiv Infection |
4.9% |
| Hodgkin's Disease |
4.9% |
| Non-hodgkin's Lymphoma |
3.5% |
| Transitional Cell Carcinoma |
3.5% |
| Depression |
2.8% |
| Synovial Sarcoma |
2.8% |
| B-cell Lymphoma |
2.1% |
| Breast Cancer |
2.1% |
| Sarcoma Metastatic |
2.1% |
| Acute Myeloid Leukaemia |
1.4% |
| Diffuse Large B-cell Lymphoma |
1.4% |
| Metastases To Bone |
1.4% |
| Multiple Myeloma |
1.4% |
| Nodal Arrhythmia |
1.4% |
| Nuclear Magnetic Resonance Imaging |
1.4% |
| Oesophagitis |
1.4% |
|
| Pancreatitis Acute |
14.7% |
| Thrombocytopenia |
11.8% |
| Sudden Death |
8.8% |
| Febrile Neutropenia |
5.9% |
| Lung Disorder |
5.9% |
| Osteomyelitis |
5.9% |
| Pancytopenia |
5.9% |
| Vomiting |
5.9% |
| Adenocarcinoma Pancreas |
2.9% |
| Bronchospasm |
2.9% |
| Chest Pain |
2.9% |
| Death |
2.9% |
| Fanconi Syndrome |
2.9% |
| Febrile Bone Marrow Aplasia |
2.9% |
| Inguinal Hernia Repair |
2.9% |
| Interstitial Lung Disease |
2.9% |
| Memory Impairment |
2.9% |
| Progressive Multifocal Leukoencephalopathy |
2.9% |
| Respiratory Failure |
2.9% |
| Weight Decreased |
2.9% |
|
